| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Target Healthcare Reit Plc |
LSE:THRL |
London |
Ordinary Share |
GB00BJGTLF51 |
ORD 1P |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
1.70 |
1.83% |
94.60 |
694,817 |
16:35:04 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
94.10
|
94.70
|
96.90 |
92.00 |
92.00 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Real Estate Investment Trusts
|
27.92
|
18.10
|
4.91
|
19.3
|
433
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 17:25:33 |
O |
1,674 |
94.605 |
GBX |
Target Healthcare Reit News
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 2020-05-26 16:25:34 | 94.61 | 1,674 | 1,583.69 | O |
| 2020-05-26 16:06:05 | 94.51 | 1,000 | 945.07 | O |
| 2020-05-26 15:35:04 | 94.60 | 90,385 | 85,504.21 | UT |
| 2020-05-26 15:29:36 | 94.70 | 156 | 147.73 | AT |
| 2020-05-26 15:28:15 | 94.40 | 1,631 | 1,539.66 | AT |
| Date | Subject |
|---|
26/5/2020
09:20 | Target Healthcare Reit Daily Update: Target Healthcare Reit Plc is listed in the Real Estate Investment Trusts sector of the London Stock Exchange with ticker THRL. The last closing price for Target Healthcare Reit was 92.90p.
Target Healthcare Reit Plc has a 4 week average price of 90.10p and a 12 week average price of 65.60p.
The 1 year high share price is 124.50p while the 1 year low share price is currently 65.60p.
There are currently 457,487,640 shares in issue and the average daily traded volume is 1,109,309 shares. The market capitalisation of Target Healthcare Reit Plc is £432,783,307.44.
|
21/10/2019
13:27 | vnvd: The number of shares and capital raised in the last few years has been quite significant. Correspondingly, portfolio value has increased 30% vs prior year in each of the last 2 years (see 2019 anual report p3). Yet, NAV and dividends per share have increased "just" 2% (probably more to do with rent revisions than by the external growth). The company might be diversifying, but in light of the results for shareholders, is growing so much necessary? (I know the investment manager likes the increased fees, but at some point we may get a bad deal)
It was already mentioned, but it seems there is still some work to as to the quality of care delivered by tenants? Inadequate service rating (the worst) as per CQC was received by 6% of THC portfolio vs 2% national average (2019 annual report).
I am considering if the share price increase of recent months might be a good time to sell...
|
Target Healthcare Reit share price data is direct from the London Stock Exchange
PLUS1
Alliance News Flash Headline